Immunocore Holdings PLC (NAS:IMCR)
$ 32.22 -0.27 (-0.83%) Market Cap: 1.61 Bil Enterprise Value: 1.21 Bil PE Ratio: 0 PB Ratio: 4.27 GF Score: 66/100

Immunocore Holdings PLC at JPMorgan Healthcare Conference Transcript

Jan 10, 2024 / 05:00PM GMT
Release Date Price: $72.71 (-1.33%)
Jessica Fye J.P. Morgan;Moderator

Good morning, everyone. My name is Jess Fye. I'm a senior biotech analyst at JP Morgan, and we're continuing the 42' Annual Healthcare Conference today with Immunocore. I'm joined on stage by the company's CEO, Bahija Jallal. She's going to give a presentation on the business, and then we're going to go into Q&A. (Operator Instructions) So with that, let me pass it over to Bahija.

Bahija Jallal Immunocore Holdings plc;CEO;Director

&

All right. Good morning, everyone. Thank you, Jess, for having us. I would like to start with a patient story. A few days ago, we met this very vibrant CEO. She was diagnosed seven years before with uveal melanoma, metastatic uveal melanoma. Her doctor said, only a few months to your daughter's graduation, but actually, you're not going to make it to that graduation. She enrolled into KIMMTRAK, and she lived seven years to tell her story. This is always what reminds me why we come to work every day, and what a privilege to be doing what we do.

So let's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot